PFE’s Stock Performance, Rising Estimates & Attractive Valuation. Pfizer’s stock has declined 6.9% in the past year compared with a decrease of 1.6% for the industry.

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. This was in early pandemic ...

Pfizer (PFE) concluded the recent trading session at $25.35, signifying a -1.17% move from its prior day's close.

Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.

Firstly, let us look at Pfizer’s stock performance in recent years. PFE stock has faced a notable decline of 30% from levels of $35 in early January 2021 to around $25 now, vs. an increase of ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Pfizer has had its own issues with falling Covid-19 vaccine sales weighing on its stock performance over the recent years. Newsletters Games Share a News Tip. ... While PFE stock looks undervalued ...

Pfizer's recent financial performance shows 14% YoY operational growth excluding COVID sales. Check out more on PFE stock here.

Going by historical performance, there is still a higher chance of a rise in PFE stock over the next month. Note that such a large move (over 20%) in a month is very rare for Pfizer and it has ...

When I saw Pfizer Inc. stock settling below pre-pandemic levels, I knew the deterioration of investor sentiment has a lot to do with declining Covid vaccine sales. This was expected. A deep dive ...